360 filings
Page 7 of 18
8-K
qqxmvpz1pd0q
8 Aug 16
Results of Operations and Financial Condition
12:00am
8-K
k7ubqsq6a1qibr3xudrb
15 Jun 16
Other Events
12:00am
8-K
ui4px
31 May 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
pksvuaz7v8ddpgen0
9 May 16
Results of Operations and Financial Condition
12:00am
8-K
q6r uiqkqme2xpnkrqhq
27 Apr 16
Other Events
12:00am
8-K
lyc60es
19 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
ts6s0ixe fi0iijt
31 Mar 16
Dynavax Announces FDA Acceptance for Review of Biologics License Application
12:00am
8-K
imh9ktj8q7kxvu6
8 Mar 16
Results of Operations and Financial Condition
12:00am
8-K
6m0er8fl
9 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
6452v1a3i
20 Jan 16
DYNAVAX and astrazeneca Amend their agreement for Asthma Drug Candidate
12:00am
8-K
vps36u
7 Jan 16
Dynavax Reports Top Line Results of Phase 3 HEPLISAV-B™ Study
12:00am
8-K
tvb8dbkxf385kd
12 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
xl2q1 8es3su14tbqrm
5 Nov 15
Results of Operations and Financial Condition
12:00am
8-K
03uss3ro 03bvsi
8 Oct 15
Other Events
12:00am
8-K
i1rz59uuc4
15 Sep 15
Other Events
12:00am
8-K
qfv1xb ilb
7 Aug 15
Results of Operations and Financial Condition
12:00am
8-K
aq7l0lr
22 Jul 15
Dynavax Prices Public Offering of Common Stock
12:00am
8-K
ei71ck6j
9 Jul 15
Results of Operations and Financial Condition
12:00am
8-K
787arq
1 Jun 15
Other Events
12:00am
8-K
wa5np mf3vwss234g
28 May 15
Submission of Matters to a Vote of Security Holders
12:00am